Abbott Laboratories (ABT) Lobbying Data
ABT lobbying summary
Abbott Laboratories (ABT) has reported $50.0M in federal lobbying spending across 275 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Taxation, Medicare/Medicaid, Trade. Lobbying firms used include Abbott Laboratories, Akin Gump Strauss Hauer & Feld, Mayer Brown LLP.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $5.0M |
| 2025 | $6.0M |
| 2024 | $6.7M |
| 2023 | $6.1M |
| 2022 | $9.4M |
| 2021 | $9.8M |
See insider trading for ABT or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.